Extremely political, obfuscation is common, and life-long employees make for low motivation & skills - Associate Director Merck Employee Review

2.0
Jul 30, 2019
Recommend
CEO approval
Business Outlook

Pros

The benefits and compensation are pretty great, but I did not find it was worth the stress and politics.

Cons

I found that most employees at Merck have been there for decades. This unfortunately results in many people who have not learned new skills and seem to be unmotivated to change themselves or their workstreams, which resulted in industry best-practices not being followed. It honestly felt like people at Merck operated in a bubble that was 15 years behind in digital marketing (saying this even taking into consideration legal pharma issues). I found it was nearly impossible to move anything forward in an environment where there is so much bureaucracy, hierarchy, politics, and sensitivity. Co-workers often seemed to justify their jobs by strangle-holding their workstreams instead of collaborating openly and without ego. It often feels like everyone is trying as hard as possible to not do anything, but still trying to appear as if they are doing something. The feeling of obfuscation is overwhelming. The physical building culture is also not ideal - in an era where many offices are going remote, the Merck UG campus building remains something straight out of Office Space.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All